Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Committee To Discuss Future COVID-19 Vaccine Purchasing Deals

Executive Summary

The health commissioner and three member state health ministers will take part in a debate on how advance purchase agreements were drawn up during the pandemic, and how they should be handled in future health crises.

You may also be interested in...



EU Generics Leaders Divided On Value Of Joint Procurement

European healthcare leaders debated the usefulness of joint procurement and state aid for the generics and biosimilars companies at a recent Politico panel, in light of rising inflation across the continent.

EU Bodies Agree Clearer Rules On Joint Procurement Of Vaccines & Treatments

The new regulation on cross-border threats to health is the final part of the European Health Union, along with strengthened roles for the European Medicines Agency and the European Centre for Disease Prevention and Control. Its aim is to ensure collective EU action on preparedness, surveillance, risk assessment, and early warning and response in the event of health emergencies.

Pressure Group Undaunted By EU Refusal To Disclose COVID-19 Vaccine Contracts

The European Commission has dismissed attempts by pressure groups to secure access to details of COVID-19 vaccine deals negotiated with pharmaceutical firms. The Corporate Europe Observatory says it is “disappointed” by the decision but is not giving up the chase.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS146916

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel